Log In
Print
BCIQ
Print
Print this Print this
 

AD03

  Manage Alerts
Collapse Summary General Information
Company Affiris AG
DescriptionVaccine against beta amyloid
Molecular Target Beta amyloid
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner

GlaxoSmithKline plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today